Haemonetics (HAE) Cash from Financing Activities (2009 - 2026)
Haemonetics (HAE) posted quarterly Cash from Financing Activities of -$101.5 million for Q1 2026, up 32.98% year-over-year from -$76.3 million in Q1 2025, and down 5092.57% quarter-over-quarter from $2.0 million in Q4 2025.
Haemonetics (HAE) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Haemonetics' Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$101.5 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 32.98% year-over-year to -$101.5 million; the TTM figure through Mar 2026 stood at -$178.5 million (down 264.0% YoY), while the FY2026 annual figure was -$178.5 million, down 264.0% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$101.5 million, down from $2.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $333.7 million in Q2 2024, with the low at -$151.4 million in Q1 2025.
- The 5-year median for Cash from Financing Activities is -$8.0 million (2022), against an average of -$7.9 million.
- Peak annual rise in Cash from Financing Activities reached 55901.34% in 2024, while the deepest fall reached 3861.45% in 2024.
- Haemonetics' Cash from Financing Activities stood at -$49.7 million in 2022, then jumped by 320.27% to $109.4 million in 2023, then tumbled by 98.74% to $1.4 million in 2024, then soared by 47.32% to $2.0 million in 2025, then slumped by 5092.57% to -$101.5 million in 2026.
- Business Quant data shows HAE's Cash from Financing Activities at -$101.5 million in Q1 2026, $2.0 million in Q4 2025, and -$76.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Haemonetics | 4.93 Bn | 4.70 Bn | 202.80 Mn | -51.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -51.53 Mn |
| Jun 27, 2026 | -51.53 Mn |
| Mar 28, 2026 | -101.50 Mn |
| Mar 28, 2026 | -101.50 Mn |
| Dec 27, 2025 | 2.03 Mn |
| Dec 27, 2025 | 2.03 Mn |
| Sep 27, 2025 | -76.55 Mn |
| Sep 27, 2025 | -76.55 Mn |
| Jun 28, 2025 | -2.44 Mn |
| Jun 28, 2025 | -2.44 Mn |
| Mar 29, 2025 | -151.45 Mn |
| Mar 29, 2025 | -151.45 Mn |
| Dec 28, 2024 | 1.38 Mn |
| Dec 28, 2024 | 1.38 Mn |
| Sep 28, 2024 | -74.80 Mn |
| Sep 28, 2024 | -74.80 Mn |
| Jun 29, 2024 | 333.69 Mn |
| Jun 29, 2024 | 333.69 Mn |
| Mar 30, 2024 | -63.50 Mn |
| Mar 30, 2024 | -63.50 Mn |